 | Analyzing Immunovant (IMVT) and The Competition
www.americanbankingnews.com - July 7 at 1:24 PM |
| Immunovant (IMVT) versus The Competition Critical Analysis
www.americanbankingnews.com - July 7 at 9:26 AM |
| Contrasting Immunovant (IMVT) and Its Competitors
www.americanbankingnews.com - July 6 at 5:35 AM |
| Short Interest in Immunovant (NASDAQ:IMVT) Decreases By 57.4%
www.americanbankingnews.com - July 5 at 10:37 PM |
| Head to Head Comparison: Immunovant (IMVT) and Its Peers
www.americanbankingnews.com - July 5 at 3:18 PM |
| Immunovant (IMVT) and Its Competitors Head-To-Head Review
www.americanbankingnews.com - July 5 at 1:22 PM |
| Contrasting Immunovant (IMVT) and Its Rivals
www.americanbankingnews.com - July 5 at 3:10 AM |
| Reviewing Immunovant (IMVT) & Its Rivals
www.americanbankingnews.com - July 5 at 3:10 AM |
| Immunovant (IMVT) & Its Competitors Head-To-Head Analysis
www.americanbankingnews.com - July 4 at 9:46 PM |
| Analyzing Immunovant (IMVT) & Its Rivals
www.americanbankingnews.com - July 4 at 1:16 PM |
| Contrasting Immunovant (IMVT) & Its Competitors
www.americanbankingnews.com - July 3 at 3:45 PM |
| Reviewing Immunovant (IMVT) & Its Peers
www.americanbankingnews.com - July 3 at 1:49 PM |
|
| Immunovant (IMVT) & Its Rivals Head to Head Comparison
www.americanbankingnews.com - July 3 at 10:31 AM |
| Critical Contrast: Immunovant (IMVT) & Its Competitors
www.americanbankingnews.com - July 2 at 3:46 PM |
| Immunovant Forecasted to Post FY2021 Earnings of ($1.53) Per Share (NASDAQ:IMVT)
www.americanbankingnews.com - July 2 at 10:13 AM |
| SVB Leerink Weighs in on Immunovant's Q1 2021 Earnings (NASDAQ:IMVT)
www.americanbankingnews.com - July 2 at 9:41 AM |
| Analyzing Immunovant (IMVT) and Its Rivals
www.americanbankingnews.com - July 2 at 1:44 AM |
| Analyzing Immunovant (IMVT) and Its Peers
www.americanbankingnews.com - July 1 at 1:53 PM |
| Analysts Offer Predictions for Immunovant's Q1 2021 Earnings (NASDAQ:IMVT)
www.americanbankingnews.com - July 1 at 9:42 AM |
| Reviewing Immunovant (IMVT) & The Competition
www.americanbankingnews.com - July 1 at 8:28 AM |
| Immunovant (NASDAQ:IMVT) Releases Earnings Results
www.americanbankingnews.com - June 30 at 7:07 AM |
 | Immunovant EPS beats by $0.20
seekingalpha.com - June 29 at 12:49 PM |
 | Immunovant Reports Financial Results for the Quarter and Fiscal Year Ended March 31, 2020 and Announces Plans for Phase 3 Registrational Trial of IMVT-1401 in Myasthenia Gravis
finance.yahoo.com - June 29 at 7:49 AM |
| Immunovant (NASDAQ:IMVT) Short Interest Down 24.3% in June
www.americanbankingnews.com - June 19 at 6:03 PM |
| Immunovant (NASDAQ:IMVT) Stock Rating Upgraded by SunTrust Banks
www.americanbankingnews.com - June 18 at 6:05 AM |
| SunTrust Banks Boosts Immunovant (NASDAQ:IMVT) Price Target to $36.00
www.americanbankingnews.com - June 17 at 3:41 PM |
| Immunovant (NASDAQ:IMVT) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - June 16 at 3:41 AM |
 | Why Immunovant (IMVT) Stock Might be a Great Pick
www.nasdaq.com - June 11 at 12:55 PM |
| Will Immunovant Continue to Surge Higher?
www.nasdaq.com - June 8 at 1:14 PM |
| IMVT Immunovant, Inc. Common Stock
www.nasdaq.com - May 20 at 12:02 PM |
 | Which way to trade Immunovant Inc (NAQ:IMVT)?
uk.finance.yahoo.com - May 13 at 7:53 AM |
 | Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
www.benzinga.com - April 16 at 6:48 PM |
| Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - April 16 at 6:48 PM |
| Immunovant prices stock offering at $14.50
seekingalpha.com - April 14 at 2:20 PM |
| Immunovant Announces Pricing of $121.2 Million Public Offering
finance.yahoo.com - April 14 at 2:20 PM |
| Immunovant files for equity offering
seekingalpha.com - April 10 at 12:29 PM |
 | AMRN's Vascepa Woes, AKRO Awaits Big Day, JNJ's COVID-19 Vaccine Study In Sep
www.rttnews.com - March 31 at 2:52 AM |
| Stock Alert: Immunovant Spikes On Results Of Its IMVT-1401
www.nasdaq.com - March 30 at 4:57 PM |
| Immunovant Announces Positive Clinical Results...
www.benzinga.com - March 30 at 8:41 AM |
| Immunovant +4% premarket on positive IMVT-1401 data
seekingalpha.com - March 30 at 8:41 AM |
| Immunovant Announces Positive Clinical Results from Ongoing Phase 2a Proof-of-Concept Study of IMVT-1401, A Novel Investigational Anti-FcRn Antibody Delivered by Subcutaneous Injection, in Thyroid Eye Disease
finance.yahoo.com - March 30 at 8:41 AM |
| Here's Why Immunovant (IMVT) Merits A Look
www.rttnews.com - March 10 at 5:18 AM |
